| Open Document File Size: 95,59 KBShare Result on Facebook
City Osaka / / Company Santen Europe / Santen Holdings EU B.V. / Santen Pharmaceutical Co. Ltd. / / Continent Europe / / Country Japan / Italy / / / Facility University of Padua / / IndustryTerm pharmaceuticals / ophthalmic pharmaceutical market / ophthalmic products / / MedicalCondition dry eye disease / European dry eye disease / inflammation / severe keratitis / / Organization Committee for Medicinal Products for Human Use / European Union / European Medicines Agency / University of Padua / European Commission / / Person Masamichi Sato / Andrea Leonardi / Takashi Hibi / / / Position General Manager Corporate Communication Group / Professor / President / Head / /
SocialTag |
News Release Santen Announces Approval of Ikervis for EU Marketing Authorization March 25, 2015 , Osaka, Japan – Santen Pharmaceutical Co., Ltd. today announced it received approval of the Marketing Authorization Appli